BUFURALOL METABOLISM IN HUMAN-LIVER - A SENSITIVE PROBE FOR THE DEBRISOQUINE-TYPE POLYMORPHISM OF DRUG OXIDATION

被引:41
作者
MINDER, EI [1 ]
MEIER, PJ [1 ]
MULLER, HK [1 ]
MINDER, C [1 ]
MEYER, UA [1 ]
机构
[1] UNIV HOSP ZURICH,DIV CLIN PHARMACOL CL-25,CH-8091 ZURICH,SWITZERLAND
关键词
D O I
10.1111/j.1365-2362.1984.tb01121.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:184 / 189
页数:6
相关论文
共 19 条
[1]  
ALVAN G, 1982, LANCET, V1, P333
[2]  
BALANT L, 1976, SCHWEIZ MED WSCHR, V106, P1403
[3]  
BOOBIS AR, 1983, 2 WORLD C CLIN PHARM
[4]   EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].
DAVIES, DS ;
KAHN, GC ;
MURRAY, S ;
BRODIE, MJ ;
BOOBIS, AR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91
[5]   THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN [J].
DAYER, P ;
BALANT, L ;
COURVOISIER, F ;
KUPFER, A ;
KUBLI, A ;
GORGIA, A ;
FABRE, J .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) :73-77
[6]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[7]   DETERMINATION OF BUFURALOL AND ITS MAJOR METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
HAEFELFINGER, P .
JOURNAL OF CHROMATOGRAPHY, 1980, 221 (02) :327-335
[8]   ASSAY AND CHARACTERIZATION OF DEBRISOQUINE 4-HYDROXYLASE ACTIVITY OF MICROSOMAL FRACTIONS OF HUMAN-LIVER [J].
KAHN, GC ;
BOOBIS, AR ;
MURRAY, S ;
BRODIE, MJ ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :637-645
[10]  
KAPITULNIK J, 1977, CLIN PHARMACOL THER, V21, P166